I'm not sure what everyone else is seeing however there is a lot...

I'm not sure what everyone else is seeing however there is a lot of dark red across my screen for those I hold and those I watch. MSB will not be immune (no pun intended!) to this and no matter how good many of us see the risk/reward ratio being, it is still a speculative investment for many. To add to this we saw a fair number of new investors/traders on the back of the Covid ARDS trial and many of those would have bought in at an SP in the 3's (mid to high for some) so is understandably a tad stressful and forcing decisions for many of that cohort. For the rest of us, we are here due to the core treatments which include two imminent P3 read outs (CHF, CLBP) and and forthcoming FDA approval (aGVHD). Not to mention off-label use for Ryoncil and more.